Respiration of Microbiota-Derived 1,2-propanediol Drives Salmonella Expansion during Colitis by Faber, Franziska et al.
RESEARCH ARTICLE
Respiration of Microbiota-Derived 1,2-
propanediol Drives Salmonella Expansion
during Colitis
Franziska Faber1, Parameth Thiennimitr2, Luisella Spiga3, Mariana X. Byndloss1,
Yael Litvak1, Sara Lawhon4, Helene L. Andrews-Polymenis5, Sebastian E. Winter3,
Andreas J. Ba¨umler1*
1 Department of Medial Microbiology and Immunology, School of Medicine, University of California Davis,
Davis, CA, United States of America, 2 Department of Microbiology, Faculty of Medicine, Chiang Mai
University, Chiang Mai, Thailand, 3 Department of Microbiology, University of Texas Southwestern Medical
Center, Dallas, TX, United States of America, 4 Department of Veterinary Pathobiology, College of Veterinary
Medicine, Texas A&M University, College Station, TX, United States of America, 5 Department of Microbial
Pathogenesis and Immunology, College of Medicine, Texas A&M University Health Science Center, Bryan,
TX, United States of America
* ajbaumler@ucdavis.edu
Abstract
Intestinal inflammation caused by Salmonella enterica serovar Typhimurium increases the
availability of electron acceptors that fuel a respiratory growth of the pathogen in the intesti-
nal lumen. Here we show that one of the carbon sources driving this respiratory expansion
in the mouse model is 1,2-propanediol, a microbial fermentation product. 1,2-propanediol
utilization required intestinal inflammation induced by virulence factors of the pathogen. S.
Typhimurium used both aerobic and anaerobic respiration to consume 1,2-propanediol and
expand in the murine large intestine. 1,2-propanediol-utilization did not confer a benefit in
germ-free mice, but the pdu genes conferred a fitness advantage upon S. Typhimurium in
mice mono-associated with Bacteroides fragilis or Bacteroides thetaiotaomicron. Collec-
tively, our data suggest that intestinal inflammation enables S. Typhimurium to sidestep
nutritional competition by respiring a microbiota-derived fermentation product.
Author Summary
Salmonella enterica serovar Typhimurium induces intestinal inflammation to induce the
generation of host-derived respiratory electron acceptors, thereby driving a respiratory
pathogen expansion, which aids infectious transmission by the fecal oral route. However,
the identity of nutrients serving as electron donors to enable S. Typhimurium to edge out
competing microbes in the competitive environment of the gut are just beginning to be
worked out. Here we demonstrate that aerobic and anaerobic respiratory pathways coop-
erate to promote growth of Salmonella on the microbial fermentation product 1,2-propa-
nediol. We propose that pathogen-induced intestinal inflammation enables Salmonella to
sidestep nutritional competition with the largely anaerobic microbiota by respiring a
microbe-derived metabolite that cannot be consumed by fermentation.
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Introduction
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a common cause of food poi-
soning. Upon ingestion, the pathogen enters the intestinal epithelium using the invasion-asso-
ciated type III secretion system (T3SS-1) [1] and deploys a second type III secretion system
(T3SS-2) to survive in host tissue [2]. This virulence strategy results in acute intestinal inflam-
mation and diarrhea [3]. Interestingly, gut inflammation increases the abundance of the path-
ogen within the gut-associated microbial community [4] by generating a respiratory nutrient-
niche (reviewed in [5]). One respiratory electron acceptor generated as a byproduct of the
inflammatory response is tetrathionate, which confers a luminal growth advantage upon S.
Typhimurium in a mouse colitis model [6] by enabling the pathogen to consume ethanol-
amine in the gut [7].
Genes involved in tetrathionate respiration and ethanolamine-utilization are intact in Sal-
monella serovars associated with gastroenteritis in humans, but are often disrupted in Salmo-
nella serovars associated with extraintestinal disease [8–10]. Another pathway often disrupted
in Salmonella serovars associated with extraintestinal disease is the utilization 1,2-propanediol
[8–10], which is produced during the fermentation of rhamnose or fucose [11]. Genes required
for the degradation of 1,2-propanediol are encoded by the porR pduF pduABCDEGHJKLM-
NOPQSTUVWX gene cluster [12], a DNA region conserved among S. enterica serovars, but
absent from the closely related species S. bongori [13–15]. Both ethanolamine and 1,2-propane-
diol-utilization proceeds through a pathway that requires a microcompartment, a respiratory
electron acceptor and the cofactor cobalamin [16]. Cobalamin biosynthesis genes are only
expressed when S. Typhimurium is cultured under anaerobic or microaerobic conditions [17,
18]. Under anaerobic conditions, tetrathionate can serve as an electron acceptor to support in
vitro growth of S. Typhimurium on 1,2-propanediol and ethanolamine by using endogenously
synthesized cobalamin [19]. Based on these observations it has been proposed that tetrathio-
nate respiration might enable S. Typhimurium to consume microbiota-derived 1,2-propane-
diol in the inflamed gut, thereby driving a luminal pathogen expansion [20]. We analyzed the
fitness of S. Typhimurium mutants in gnotobiotic or conventional mice to test this prediction.
Results
1,2-propanediol-utilization confers a growth advantage during
inflammation
To determine whether 1,2-propanediol-utilization confers a benefit in the environment of the
large intestine, we constructed a S. Typhimurium strain lacking the pduABCDEGHJKLMNOPQ-
STUVWX gene cluster (pduA-X mutant) (Fig 1A). Compared to the S. Typhimurium wild type
strain the pduA-X mutant grew poorly in minimal medium containing 1,2-propanediol as car-
bon source (Fig 1B), but showed no growth defect in rich medium (S1A Fig). Genetically resis-
tant (CBA) mice were infected intragastrically with a 1:1 mixture of the S. Typhimurium wild
type (IR715) and a pduA-X mutant (FF128) to compare the fitness of both strains. By 14 days
after infection, the S. Typhimurium wild type was recovered in significantly higher numbers
from cecal and colon contents than a pduA-X mutant (P< 0.01), suggesting that 1,2-propanediol
utilization conferred a benefit for growth of the pathogen in the large intestine (Figs 1C and
S2A). Similar results were obtained with a S. Typhimurium mutant carrying an insertion in the
pduC gene (S1B and S2B Figs). After bypassing the gut by the intraperitoneal route of inocula-
tion, the S. Typhimurium wild type was recovered in similar numbers as a pduA-X mutant from
organs of mice infected with a 1:1 mixture of both strains (S2C Fig). Growth of the pduA-X
1,2-propanediol-Utilization by Salmonella
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mutant in genetically resistant mice could be restored by re-introducing the intact pdu operon
through transduction (FF484) (S2D Fig).
Next, we infected mice with either the S. Typhimurium wild type or a pduA-X mutant. By
14 days, mice infected with the S. Typhimurium wild type carried a significantly higher patho-
gen burden in colon contents than mice infected with a pduA-X mutant (P< 0.05) (Fig 1D),
although no significant differences in the severity of intestinal pathology between both groups
were noted (S2E Fig).
Since genetically resistant mice develop severe intestinal inflammation by approximately 10
days after infection [21], we wanted to investigate whether the fitness advantage conferred by
1,2-propanediol utilization genes required severe colitis induced by virulence factors. To this
end, T3SS-1 and T3SS-2 were inactivated using mutations in the invA and spiB genes, respec-
tively. When mice (CBA) were infected intragastrically with a 1:1 mixture of an invA spiB
mutant (FF183) and a invA spiB pduA-X mutant (FF383), both strains were recovered in simi-
lar numbers from cecal and colon contents 14 days after infection (Fig 1C). Mice infected with
virulent S. Typhimurium strains (i.e. a mixture of wild type and pduA-X mutant) developed
Fig 1. 1,2-propanediol utilization confers an advantage during growth in the inflamed murine
intestine. (A) Genetic organization of the pdu operon. (B) Anaerobic growth of S. Typhimurium wild
type and the pduA-X mutant in minimal medium supplemented with 5 mM 1,2-propanediol and 40 mM
tetrathionate. Data points represent geometric means ± standard error of the mean (s.e.m.) of bacterial
numbers (CFU/ml) recovered at the indicated time points. (C and E) CBA mice were mock infected
(mock) or infected intragastrically with a 1:1 mixture of the indicated S. Typhimurium strains. N is indica-
ted in panel E. (C) Bars represent geometric means ± s.e.m. of the competitive indices. (D) CBA mice
were infected intragastrically with 109 CFU of either the S. Typhimurium wild type (wt) or a pduA-X
mutant. N is indicated in S2E Fig. Bars represent geometric means ± s.e.m. of bacteria recovered from
colon contents (CFU/g). (E) Histopathological changes were scored in sections of the cecum. Each bar
represents the combined scoring results for one individual animal. (F) Representative images of
histological sections from the cecum. Scale bar represents 100 μm. M, mucosa; s, submucosa; ml,
muscularis; * P < 0.05, *** P < 0.001.
doi:10.1371/journal.ppat.1006129.g001
1,2-propanediol-Utilization by Salmonella
PLOS Pathogens | DOI:10.1371/journal.ppat.1006129 January 5, 2017 3 / 19
severe acute inflammation in the cecal mucosa, while no marked inflammatory changes were
observed in mice infected with avirulent S. Typhimurium strains (i.e. a mixture of invA spiB
mutant and invA spiB pduA-X mutant) (Fig 1E and 1F). These data suggested that the utiliza-
tion of 1,2-propanediol conferred a fitness advantage upon S. Typhimurium during growth in
the inflamed intestine.
Tetrathionate respiration is dispensable for 1,2-propanediol-utilization in
vivo
A variety of exogenous electron acceptors can be generated during intestinal inflammation,
including tetrathionate, nitrate, organic S-oxides (such as DMSO) or organic N-oxides (such
as TMAO), which support growth by anaerobic respiration (summarized in [22]). We next
investigated whether exogenous electron acceptors would support anaerobic growth of S.
Typhimurium on 1,2-propanediol in vitro. To this end, minimal medium containing 1,2-pro-
panediol as the sole carbon source was supplemented with tetrathionate, nitrate, dimethyl sulf-
oxide (DMSO) or trimethylamine N-oxide (TMAO) and inoculated with a 1:1 mixture of the
S. Typhimurium wild type and a pduA-X mutant. The ability to utilize 1,2-propanediol con-
ferred the largest fitness advantage in media supplemented with tetrathionate, followed by
media supplemented with nitrate, DMSO and TMAO (Fig 2A). In contrast, 1,2-propanediol-
utilization did not confer a growth advantage in the absence of exogenous electron acceptors,
which was consistent with a previous report [19]. Growth of the pduA-X mutant on 1,2-propa-
nediol in media supplemented with tetrathionate could be restored by re-introducing the
intact pdu operon through transduction (FF484).
Since tetrathionate becomes available during inflammation [6], it has been proposed that
this electron acceptor might enable S. Typhimurium to utilize 1,2-propanediol during colitis
Fig 2. Tetrathionate respiration supports growth of S. Typhimurium on 1,2-propanediol in vitro, but
is not essential for 1,2-propanediol utilization in vivo. (A) Competitive growth (N = 5) of the indicated S.
Typhimurium strains on 1,2-propanediol under microaerobic conditions (0.8% oxygen) or anaerobically in
the presence of tetrathionate (S4O62-), nitrate (NO3-), dimethyl sulfoxide (DMSO) or trimethylamine N-oxide
(TMAO). Bars represent geometric means ± s.e.m. of the competitive index (CI) recovered after 24 hours. (B)
CBA/J mice (N = 4) were infected with a 1:1 mixture of the indicated S. Typhimurium strains. Bars represent
geometric means ± s.e.m. of the CI. * P < 0.05, NS not statistically significantly different; wt, S. Typhimurium
wild type; pduA-X, pduA-X mutant; pduA-X restored, the intact pdu operon was introduced into the pduA-X
mutant by transduction; ttrA, ttrA mutant; ttrA pduA-X, ttrA pduA-X mutant.
doi:10.1371/journal.ppat.1006129.g002
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[20]. To test this prediction, we inactivated the ttrA gene, encoding tetrathionate reductase
and infected genetically resistant (CBA) mice intragastrically with a 1:1 mixture of a S. Typhi-
murium ttrA mutant (SW661) and a ttrA pduA-X mutant (PT305). Surprisingly, 1,2-propane-
diol-utilization conferred a fitness advantage even after genetic ablation of tetrathionate
respiration by a mutation in ttrA (Fig 2B). These data refuted the hypothesis that tetrathionate
respiration was necessary for the growth benefit conferred by 1,2-propanediol-utilization.
Anaerobic respiration is not the only driver of 1,2-propanediol-utilization
The enzymes that enable S. Typhimurium to use tetrathionate, nitrate, organic S-oxides (such
as DMSO) or organic N-oxides (such as TMAO) as respiratory electron acceptors under anaer-
obic conditions contain molybdopterin, a cofactor also required for the use of formate as an
electron donor (reviewed in [22]). To determine whether anaerobic respiration contributed to
1,2-propanediol-utilization, we inactivated the S. Typhimurium moaA gene, encoding the
enzyme catalyzing the first step in the molybdopterin cofactor biosynthesis. Genetically resis-
tant (CBA) mice were inoculated intragastrically with a 1:1 mixture of the S. Typhimurium
wild type and a pduA-X mutant or with a 1:1 mixture of a moaA mutant (FF294) and a moaA
pduA-X mutant (FF284). Interestingly, mutational inactivation of moaA did not abrogate the
fitness advantage conferred by 1,2-propanediol-utilization (Fig 3A). These data suggested that
exogenous electron acceptors for anaerobic respiration were not solely responsible for the abil-
ity of S. Typhimurium to utilize 1,2-propanediol during colitis.
Aerobic and anaerobic respiration contribute to 1,2-propanediol-
utilization
S. Typhimurium-induced colitis is accompanied by increased epithelial oxygenation, driving a
cytochrome bd-II oxidase-dependent aerobic pathogen expansion by 10 days after infection of
Fig 3. Aerobic and anaerobic respiration cooperates to support growth of S. Typhimurium on
1,2-propanediol in the inflamed intestine. CBA mice (A) or streptomycin treated C57BL/6 mice (B) were orally
infected with a 1:1 mixture of the indicated S. Typhimurium strains. Bars represent geometric means ± s.e.m. of the
competitive indices determined at the indicated time points. (A) wt vs. pduA-X, N = 4; moaA vs. moaA pduA-X,
N = 9; cyxA vs. cyxA pduA-X, N = 9; moaA cyxA vs. moaA cyxA pduA-X, N = 10. (B) wt vs. pduA-X, N = 4; invA spiB
vs. invA spiB pduA-X, N = 6; moaA vs. moaA pduA-X, N = 5; cyxA vs. cyxA pduA-X, N = 6; moaA cyxA vs. moaA
cyxA pduA-X, N = 5.
doi:10.1371/journal.ppat.1006129.g003
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genetically resistant (CBA) mice [21]. We therefore deleted cyxA, the gene encoding cyto-
chrome bd-II oxidase, to investigate whether aerobic respiration contributed to 1,2-propane-
diol-utilization. Genetically resistant (CBA) mice were inoculated intragastrically with a 1:1
mixture of a cyxAmutant (FF286) and a cyxA pduA-X mutant (FF288). Deletion of cyxA did
not abrogate the fitness advantage conferred by 1,2-propanediol-utilization (Fig 3A).
To determine whether 1,2-propanediol-utilization involved cooperation between aerobic
and anaerobic respiration, genetically resistant (CBA) mice were infected with a 1:1 mixture of
a cyxAmoaA mutant (FF296) and a cyxAmoaA pduA-X mutant (FF292). Remarkably, genetic
ablation of both aerobic respiration (through inactivation of cyxA) and anaerobic respiration
(through inactivation of moaA) abrogated the fitness advantage conferred by 1,2-propanediol-
utilization (P 0.05) (Fig 3A).
Next, we studied the role of 1,2-propanediol-utilization in mice that were genetically sus-
ceptible to S. Typhimurium infection (C57BL/6 mice). Genetically susceptible (C57BL/6) mice
become moribund before developing severe acute intestinal inflammation during S. Typhi-
murium infection. However, preconditioning of C57BL/6 mice with streptomycin disrupts the
resident microbiota and leads to severe acute cecal inflammation during S. Typhimurium
infection [23]. Streptomycin-treated C57BL/6 mice were infected intragastrically with a 1:1
mixture of the S. Typhimurium wild type and a pduA-X mutant or with a 1:1 mixture of an
invA spiB mutant and a invA spiB pduA-X mutant. Four days after infection, 1,2-propanediol-
utilization conferred a fitness advantage upon S. Typhimurium, as indicated by higher recov-
ery of the wild type than a pduA-X mutant (Fig 3B and S3 Fig). In contrast, similar numbers of
the invA spiB mutant and an invA spiB pduA-X mutant were recovered from colon contents.
These data provided further support for the idea that benefit conferred by 1,2-propanediol-uti-
lization required the presence of virulence factors.
In streptomycin-treated C57BL/6 mice, inactivation of either moaA or cyxA reduced the fit-
ness advantage conferred by 1,2-propanediol-utilization (Fig 3B). Collectively, these data pro-
vided further support for the idea that S. Typhimurium used both aerobic and anaerobic
respiration to consume 1,2-propanediol during colitis.
Salmonella requires the gut microbiota to benefit from 1,2-propanediol-
utilization
Saccharolytic bacteria in the large intestine break down complex carbohydrates, thereby liber-
ating monosaccharides, such as fucose and rhamnose, which can be fermented to generate
1,2-propanediol [11]. To investigate whether utilization of 1,2-propanediol by S. Typhimurium
required members of the gut-associated microbial community, germ-free (Swiss-Webster)
mice were infected with a 1:1 mixture of the S. Typhimurium wild type and a pduA-X mutant.
Equal recovery of both strains from colon contents suggested that in the absence of the gut
microbiota, 1,2-propanediol-utilization did not confer a luminal growth advantage in the
mouse intestine (Fig 4A and 4B). When mice mono-associated with Bacteroides fragilis or Bac-
teroides thetaiotaomicron were infected with a 1:1 mixture of the S. Typhimurium wild type
and a pduA-X mutant, 1,2-propanediol-utilization conferred a fitness advantage (Fig 4A and
4B), which was not due to changes in intestinal inflammation between the groups (Fig 4C and
4D), suggesting that S. Typhimurium required the presence of saccharolytic bacteria to utilize
1,2-propanediol in the gut.
Next, we determined whether B. thetaiotaomicron was a source of 1,2-propanediol in the
large intestine. To this end, germ-free mice were mock-inoculated or mono-associated with B.
thetaiotaomicron and the concentration of 1,2-propanediol in colon contents was determined
by gas chromatography/mass spectrometry (GC/MS). In mock-inoculated germ-free mice, the
1,2-propanediol-Utilization by Salmonella
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concentration of 1,2-propanediol was close to the limit of quantification. In contrast, 1,2-pro-
panediol was present at a concentration of approximately 40 μM in B. thetaiotaomicron mono-
associated mice (Fig 4E). These data suggested that B. thetaiotaomicron is a source of 1,2-pro-
panediol in the large intestine. To investigate whether consumption of 1,2-propanediol by S.
Typhimurium would reduce the luminal concentration of this metabolite, mice mono-associ-
ated with B. thetaiotaomicron were infected with the S. Typhimurium wild type or a pduA-X
mutant. While there was a trend that the luminal 1,2-propanediol concentrations were lower
in mice infected with the wild type compared to those infected with the pduA-X mutant, this
difference did not reach statistical significance (Fig 4E).
Next, we determined whether the ability of the pathogen to generate 1,2-propanediol
through fermentation of rhamnose or fucose was necessary for its ability to utilize 1,2-propa-
nediol. To this end, we generated S. Typhimurium mutants lacking rhaBAD or fucO, respec-
tively. A S. Typhimurium rhaBAD mutant was unable to ferment rhamnose (Fig 4F), but
Fig 4. Salmonella requires the gut microbiota to benefit from 1,2-propanediol-utilization. (A-B) Germ-
free Swiss Webster mice or ex germ-free mice pre-colonized with either B. thetaiotaomicron (B. theta) or B.
fragilis for 7 days were infected intragastrically with a 1:1 mixture of S. Typhimurium wild type and a pduA-X
mutant. Bars represent geometric means ± s.e.m. of the competitive index (CI) recovered from colon contents
(A) or cecal contents (B). N is indicated in panel C. (C) Histopathological changes were scored for sections of
the cecum. (D) Representative images of histological sections from the cecum. Scale bar represents 100 μm.
m, mucosa; s, submucosa; ml, muscularis. (E) Germ-free Swiss Webster mice or ex germ-free mice mono-
associated with B. thetaiotaomicron for 7 days (N = 6) were infected intragastrically with the indicated S.
Typhimurium strains and the 1,2-propanediol concentration was determined 3 days later. Bars represent
geometric means ± s.e.m.; LOQ, limit of quantification. (F) Medium containing the sugars indicated at the top
was inoculated with the S. Typhimurium strains indicated on the right. Sugar fermentation was detected
through the color change (blue to yellow) of a pH indicator. (G) A pduC mutant or a fucO mutant was grown
anaerobically in minimal medium containing fucose as a sole carbon source. The spent culture medium was
supplemented with tetrathionate and inoculated with the indicated mixture of S. Typhimurium strains to
determine the CI after anaerobic growth. (H) Germ-free mice (N = 4) were mono-associated with B.
thetaiotaomicron and inoculated with the indicated strain mixtures. (G and H) Bars represent geometric
means ± s.e.m. of the competitive index (CI).
doi:10.1371/journal.ppat.1006129.g004
1,2-propanediol-Utilization by Salmonella
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exhibited no growth defect in complex culture medium (S1C Fig). Inactivation of 1,2-propane-
diol utilization by deleting pduC or pduA-X did not abrogate the ability of S. Typhimurium to
ferment rhamnose or fucose (Fig 4F). The fucO gene encodes 1,2-propanediol oxidoreductase,
the enzyme catalyzing the interconversion of lactaldehyde to 1,2-propanediol [24]. Deletion of
fucO did not abrogate the ability of S. Typhimurium to ferment fucose (Fig 4F) and did not
produce a growth defect in complex culture medium (S1C Fig). We next generated spent cul-
ture medium by growing a pduC mutant or a fucO mutant anaerobically in minimal medium
containing fucose as a sole carbon source. The spent culture medium generated in this fashion
was sterilized, supplemented with tetrathionate and inoculated with a 1:1 mixture of the S.
Typhimurium wild type and a pduC mutant. 1,2 propanediol-utilization did not confer a fit-
ness advantage for anaerobic growth in spent culture medium from a fucO mutant (Fig 4G),
suggesting that the fucO mutant was no longer able to generate 1,2-propanediol as a product of
fucose fermentation. We then investigated whether S. Typhimurium strains unable to generate
1,2-propanediol from fucose (fucO mutant), rhamnose (rhaBAD mutant) or either pentose
(fucO rhaBAD mutant) were still able to use the pdu operon for expansion in the large intestine
of gnotobiotic mice mono-associated with B. thetaiotaomicron. The pdu operon still conferred
a significant fitness advantage upon S. Typhimurium strains that could generate 1,2-propane-
diol neither from fucose nor from rhamnose (Fig 4H), suggesting that 1,2-propanediol gener-
ated by B. thetaiotaomicron (Fig 4E) was sufficient to stimulate growth of the pathogen.
Collectively, these data demonstrated that microbe-derived 1,2 propanediol was a critical
carbon source for S. Typhimurium, which drove an expansion of the pathogen population
during colitis.
Discussion
Associations revealed by genome and literature mining predict that propanediol utilization
pathways are genomic determinants of pathogenicity associated with food poisoning, presum-
ably by promoting growth in the low-oxygen environment of the large intestine [25]. For
example, adherent-invasive Escherichia coli (AIEC) isolated from intestines of patients with
Crohn’s disease (CD) contain genes encoding 1,2-propanediol-utilization, while the gene clus-
ter is commonly absent from commensal E. coli isolates [26]. Comparative genomic analysis of
S. enterica serovars suggest that loci involved in 1,2-propanediol utilization are intact in patho-
gens causing gastrointestinal disease, such as S. enterica serovars Typhimurium or Enteritidis,
but are often disrupted in closely related pathogens associated exclusively with extraintestinal
disease, such as S. enterica serovars Typhi, Paratyphi A, Gallinarum or Choleraesuis [8–10].
S. Typhimurium growth under conditions mimicking the low-oxygen high-osmolarity
environment of the gut induces the synthesis of proteins involved in the utilization of 1,2-pro-
panediol [27]. Transcriptional profiling suggests that 1,2-propanediol utilization genes are
expressed during S. Typhimurium growth in the ceca of chickens [28] and in gnotobiotic mice
mono-associated with B. thetatiotaomicron [29]. Collectively, studies on gene regulation and
the in silico predictions reviewed above imply that 1,2-propanediol utilization genes might
contribute to S. Typhimurium growth in the large intestine, but the present report is the first
to test this hypothesis using an animal model. Our results provide compelling experimental
support for the idea that 1,2-propanediol-utilization contributes to growth of S. Typhimurium
during gastroenteritis, suggesting that the pathogen thrives during gut inflammation in part by
respiring fermentation products generated by other microbes.
While tetrathionate respiration is necessary for growth on ethanolamine in vivo [7], effi-
cient 1,2-propanediol-utilization in the mouse intestine required both aerobic and anaerobic
respiration. Interestingly, 1,2-propanediol represses transcription of ethanolamine utilization
1,2-propanediol-Utilization by Salmonella
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genes to avoid detrimental mixing of shell proteins from the corresponding microcompart-
ments [30]. Thus, the finding that different electron acceptors are required to breakdown
1,2-propanediol and ethanolamine in vivo may reflect the need to prevent simultaneous
expression of the pdu and eut gene clusters. In turn, this may restrict utilization of 1,2-propa-
nediol and ethanolamine to microenvironments that differ with regard to electron acceptor
availability. However, additional work is needed to test this prediction.
1,2-propanediol is generated by the gut microbiota through fermentation of methyl-pen-
toses, such as fucose or rhamnose [11]. Glycoside hydrolases and polysaccharide lyases
expressed by the gut microbiota can liberate fucose from complex carbohydrates [29] (Fig 5).
Members of the class Bacteroidia encode the most diverse array of glycoside hydrolases and
polysaccharide lyases, suggesting that this group possesses the largest carbohydrate substrate
range within the gut-associated microbial community [31]. Consistent with this idea, 1,2-pro-
panediol-utilization conferred a benefit upon S. Typhimurium in mice mono-associated with
B. fragilis or B. thetaiotaomicron, but not in germ-free mice.
Fig 5. Schematic of S. Typhimurium 1,2-propanediol utilization during colitis. The enteric pathogen S.
Typhimurium (Salmonella) uses its virulence factors (T3SS-1 and T3SS-2) to elicit severe acute intestinal
inflammation. A side-product of the host inflammatory response is the generation of exogenous electron acceptors,
which creates a respiratory nutrient-niche in the lumen of the large intestine. A combination of aerobic and anaero-
bic respiration enables S. Typhimurium to expand in the inflamed intestine by consuming microbe-derived 1,2-
propanediol, a metabolite produced during the fermentation of fucose or rhamnose. Monosaccharides, such as
fucose and rhamnose, are liberated by the gut microbiota from complex carbohydrates, which escape digestion by
host enzymes in the upper intestinal tract and reach the colon.
doi:10.1371/journal.ppat.1006129.g005
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The picture emerging from this and previous work is that respiratory electron acceptors
become available during S. Typhimurium-induced colitis [6, 21, 32, 33], which enables the path-
ogen to consume 1,2-propanediol, a process that could be viewed as “dumpster diving” for a fer-
mentation product produced by the gut microbiota [34] (Fig 5). Respiration of 1,2-propanediol
allows S. Typhimurium to side-step nutritional competition with the fermenting gut microbiota
to drive its expansion within the lumen of the large bowel. This outcome is biologically relevant,
because an uncontrolled expansion of S. Typhimurium during colitis is important for infectious
transmission by the fecal oral route [21, 35].
Materials and Methods
Ethics statement
This study was performed in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health and approved by the
Institutional Animal Care and Use Committee at the University of California at Davis (proto-
cols #15449, 17140, 17939 and 19235).
Bacterial strains and plasmids
All strains used in this study are listed in Table 1. S. Typhimurium and E. coli cultures were
routinely grown aerobically at 37˚C in either Luria-Bertani (LB) broth (10 g/l tryptone, 5 g/l
yeast extract, 10 g/l NaCl) or on LB agar plates (1.5% Difco agar) unless indicated otherwise.
When necessary, antibiotics were added to the medium at the following concentrations: Nali-
dixic acid (Nal) 50 mg/l, Kanamycin (Km) 100 mg/l, Chloramphenicol (Cm) 30 mg/l, Carbeni-
cillin (Carb) 100 mg/L. B. thetaiotaomicron and B. fragilis were routinely grown inside an
anaerobe chamber (Bactron I Anaerobic Chamber; Sheldon Manufacturing, Cornelius) at
37˚C in either Tryptic Soy Broth (TSB) or on Tryptic Soy agar (TSA) plates (1.5% [w/v] Difco
agar) supplemented with 5% (v/v) sheep blood.
Construction of S. Typhimurium mutants
All strains, plasmids and primers used in this study are listed in Tables 1–3. Standard cloning
techniques were used to generate the plasmids used in this study. PCR products were con-
firmed by sequencing (SeqWright Fisher Scientific, Houston). Suicide plasmids were propa-
gated in E. coli DH5α λpir. Phage P22 HT int-105 was used for generalized transduction.
Transductants were cleaned from phage contamination on Evans blue-Uranine (EBU) plates
and tested for phage sensitivity by cross-streaking against P22 H5.
To construct the pduA-X mutant (FF128), a region upstream and downstream of pduA and
pduX, respectively, were PCR amplified from the S. Typhimurium wild-type strain IR715. Both
PCR products (the flanking regions of pduA and pduX genes) were subcloned into pCR2.1 to
obtain pPT33 and pPT34, respectively. The inserted PCR fragments were confirmed by sequenc-
ing. The pduA fragment from pPT33 was cloned into the suicide plasmid pGP704 by using SalI
and XbaI restriction sites to obtain pPT35. The pduX fragment from pPT34 was digested by
XbaI and SmaI and then inserted into pPT35 to yield pPT36. Next, the Kanr cassette from pBS34
was inserted into pPT36 to obtain pPT37. Plasmid pPT37 was transformed into E. coli S17-1λpir.
Plasmid pPT37 was conjugated into the S. Typhimurium wild type (IR715) and an invA spiB
mutant (SPN487) using E. coli S17-1λpir as a donor strain to generate FF128 (IR715 pduA-X::
KanR) and FF383 (IR715 invA spiB pduA-X::KanR), respectively. Exconjugants were plated onto
LB+Nal+Kan and tested for CarbS to select for clones that carried the deletion.
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To construct the moaA mutant, a region upstream and downstream of moaA were PCR
amplified from the S. Typhimurium wild-type strain IR715 introducing XbaI and SalI restric-
tion sites into both fragments. Then, both PCR products were digested with XbaI ligated
together and cloned into pRDH10 using SalI restriction sites yielding plasmid pCAL25. The
inserted PCR fragments were confirmed by sequencing. Plasmid pCAL25 was conjugated into
S. Typhimurium IR715 (wild-type) and FF176 (phoN::Tn10d-Cam) using E. coli S17-1λpir as a
donor strain to generate FF283 (IR715 moaA) and FF294 (phoN::Tn10d-Cam moaA), respec-
tively. Exconjugants were plated onto LB+Nal+Cm to select for clones that had integrated the
suicide plasmid. Sucrose counter-selection was performed as published previously [36]. Strains
that were sucrose resistant and CmS were verified by PCR.
Table 1. Bacterial strains used in this study.
Designation Genotype Reference
S. Typhimurium strains
IR715 Nalidixic acid-resistant derivative of ATCC 14028s [40]
FF176 IR715 phoN::Tn10d-Cam [41]
SPN487 IR715 invA spiB [41]
FF183 IR715 phoN::Tn10d-Cam invA spiB [41]
SDL175 IR715 pduC::KanR This study
FF128 IR715 pduA-X::KanR This study
FF383 IR715 invA spiB pduA-X::KanR This study
SW661 IR715 ttrA::pSW171 [6]
PT305 IR715 ttrA::pSW171 pduA-X::KanR This study
FF283 IR715 ΔmoaA This study
FR102 IR715 cyxA::pPT48 [21]
FF294 IR715 phoN::Tn10d-Cam ΔmoaA This study
FF284 IR715 moaA pduA-X::KanR This study
FF286 IR715 phoN::Tn10d-Cam cyxA::pPT48 This study
FF288 IR715 cyxA::pPT48 pduA-X::KanR This study
FF296 IR715 phoN::Tn10d-Cam moaA cyxA::pPT48 This study
FF292 IR715 moaA cyxA::pPT48 pduA-X::KanR This study
FF489 IR715 rhaBAD This study
FF495 IR715 rhaBAD pduA-X::KanR This study
FF499 IR715 phoN::Tn10d-Cam rhaBAD This study
PT206 IR715 fucO::pPT21 This study
FF509 IR715 phoN::Tn10d-Cam fucO::pPT21 This study
FF497 IR715 fucO::pPT21 pduA-X::KanR This study
FF505 IR715 phoN::Tn10d-Cam rhaBAD fucO::pPT21 This study
FF503 IR715 rhaBAD fucO::pPT21 pduA-X::KanR This study
FF480 IR715 pduP::pRDH10 This study
FF484 FF128 restored to wild type This study
Bacteroides strains:
B. thetaiotaomicron VPI-5482 Isolate from human feces ATCC 29148
B. fragilis Isolate from appendix abscess ATCC25285
E. coli strains:
DH5α λpir F- endA1 hsdR17 (r-m+) supE44 thi-1 recA1 gyrA relA1 Δ(lacZYA-argF)U189 ϕ80lac ΔM15 λpir [42]
S17-1 λpir C600::RP4 2-(Tet::Mu) (Kan::Tn7) λpir recA1 thi pro hsdR (r-m+) [43]
TOP10 ϕ80lacZΔM15 lacX74 recA1 araD139 Δ(ara-leu) 7697 galU galK rpsL endA1 nupG Invitrogen
doi:10.1371/journal.ppat.1006129.t001
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Table 3. Primers used in this study.
Primer Sequence in 5’ - 3’
Deletion of pduA-X operon
pduA-P1 TCTAGAAGACCTCGCATGGAG
pduA-P2 GTCGACCATTGCGCCTTTAG
pduX-P3 TCTAGAAGCCTGATATACGC
pduX-P4 CCCGGGCTAACGATCGCCCAC
Deletion of moaA
moaA-P1 ATCTTAGTCGACGGCAGACTCAGTTCG
moaA-P2 GACGAGTCTAGAGAGTGTTTACTGTGG
moaA-P3 TAAGAATCTAGAGCGGCGAAGAAGACG
moaA-P4 CCAGTTGTCGACTCAGTTCCTGTAAGC
Deletion of pduC
STM20405’+P1 CGATCGTCCGTCCTACATCTGATACCCACGAGGCTGATTCGTGTAGGCTGGAGCTGCTTC
STM20403’+P2 CTGGCGCAGCAATTTTTCATTAATTTCCATTTCTCACCCCCATATGAATATCCTCCTTAG
STM2040 5’ CTCGGTTCTGAACCGAAAAA
STM2040 3’ CGGAGTACGTCTTCAATTAT
Deletion of rhaBAD operon
rhaBAD-P1 TCATGGCGACCACACCCGTCCTGTGTCAAACCGAAGGTTTCATC
rhaBAD -P2 TGCCCGATTATTTCGAATACGCCGTTTATCG
rhaBAD -P3 AACGGCGTATTCGAAATAATCGGGCATCAGCAG
rhaBAD -P4 CGGCCACGATGCGTCCGGCGTAGAGAGCAAACACCGTACCCTG
Deletion of fucO operon
fucO-P1 GGTACCAGCGCTGATTGTTACCG
fucO-P2 GATATCGCATGGGTTAGCGC
Restoration of FF128 (pduA-X::KanR)
pduP-P1 GAATTCGCGTTATCGGTTCGG
pduP-P2 GAATTCCTTTCACCAGGTCCGC
doi:10.1371/journal.ppat.1006129.t003
Table 2. Plasmids used in this study.
Designation Relevant characteristic Reference
pCR2.1 Cloning vector Invitrogen
pGP704 ori(R6K) mobRP4 CarbR [44]
pRDH10 ori(R6K) mobRP4 sacRB TetR CmR [45]
pBS34 pBluescript II KS+, KSAC cassette, CarbR, KmR [46]
pPT33 pCR2.1 with region upstream of pduA This study
pPT34 pCR2.1 with region downstream of pduX This study
pPT35 pGP704 with region upstream of pduA This study
pPT36 pGP704 with regions upstream of pduA and downstream of pduX This study
pPT37 pGP704 with KanR cassette inserted between pduA and pduX fragments This study
pPT48 pGP704 carrying an internal fragment of cyxA (annotated as STM14_0423 in ATCC 14028s) [21]
pCAL25 pRDH10 carrying up-/downstream regions of moaA This study
pRhaBAD pRDH10 carrying flanking regions of rhaBAD This study
pPT20 pCR2.1 carrying an internal fragment of fucO This study
pPT21 pGP704 carrying an internal fragment of fucO This study
pCR-pduP pCR2.1 carrying an internal fragment of pduP This study
pRDH10-pduP pRDH10 carrying an internal fragment of pduP This study
pKD4 Carries the KanR inserted in pduC [37]
pKD46 Carries λ Red recombinase under an arabinose inducible promoter [37]
doi:10.1371/journal.ppat.1006129.t002
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The pduC mutant was constructed using the λ Red recombinase method as previously descri-
bed [37]. PCR products were generated using primers STM20405’+P1 and STM20403’+S2 with
pKD4 as the DNA template [37]. The appropriate length of the PCR products, approximately 1.6
kb, was ensured by agarose gel electrophoresis. The PCR product was electroporated into electro-
competent ATCC14028 carrying pKD46, a temperature sensitive plasmid which carries λ Red
recombinase under an arabinose inducible promoter [37]. The recipient was prepared as previ-
ously described [37]. Following electroporation, transformants were allowed to recover for 1
hour at 37˚C and were then plated onto LB+Kan and grown at 37˚C to select for clones that
had integrated the PCR product. Insertion of the KanR was confirmed by PCR using primers
STM2040 5’ with previously described primer k1 and STM2040 3’ with primer k2 [37]. The
mutation was also confirmed by Southern blot using a digoxigenin-labeled probe generated by
PCR using primers k1 and kt with pKD4 DNA as template. A P22 lysate of the resultant strain
was used to transduce the pduC::KanR into IR715 to generate SDL175.
To construct the rhaBAD mutant, regions flanking the rhaBAD operon were PCR amplified
from the S. Typhimurium wild-type strain IR715 and cloned into BamHI-digested pRDH10
using Gibson Assembly Master Mix (NEB) yielding plasmid pRhaBAD. Plasmid pRhaBAD
was conjugated into S. Typhimurium IR715 (wild-type) and FF128 (pduA-X::KanR) using E.
coli S17-1λpir as a donor strain to generate FF489 (IR715 rhaBAD) and FF495 (rhaBAD pduA-
X::KanR), respectively. Exconjugants were plated onto LB+Nal+Cm to select for clones that
had integrated the suicide plasmid. Sucrose counter-selection was performed as published pre-
viously [36]. Strains that were sucrose resistant and CmS were verified by PCR.
To construct the fucO mutant, an internal fragment of the fucO gene was PCR amplified
from the S. Typhimurium wild-type strain IR715 and cloned into pCR2.1 to generate pPT20.
The fucO fragment from pPT20 was cloned into suicide plasmid pGP704 to obtain pPT21.
Using E. coli S17-1λpir as a donor strain, plasmid pPT21 was conjugated into S. Typhimurium
wild type (IR715), the phoN::Tn10d-Cam rhaBAD mutant (FF499) and the rhaBAD pduA-X::
KanR mutant (FF495) to generate PT206 (IR715 fucO::pPT21), FF505 (IR715 phoN::Tn10d-
Cam rhaBAD fucO::pPT21) and FF503 (IR715 rhaBAD fucO::pPT21 pduA-X::KanR), respec-
tively. Exconjugants were plated onto LB+Nal+Carb to select for clones that carried the plas-
mid insertion.
A P22 lysate of strain FF128 was used to transduce the pduA-X::KanR mutation into SW661
(ttrA), FF283 (moaA), FR102 (cyxA::pPT48) and PT206 (fucO::pPT21) to obtain strains PT305
(ttrA::pSW171 pduA-X::KanR) FF284 (moaA pduA-X::KanR), FF288 (cyxA::pPT48 pduA-X::
KanR) and FF497 (fucO::pPT21 pduA-X::KanR), respectively.
A P22 lysate of strain FR102 was used to transduce the cyxA::pPT48 mutation into FF176
(phoN::Tn10d-Cam), FF294 phoN::Tn10d-Cam moaA) and FF284 (moaA pduA-X::KanR) to
generate strains FF286 (phoN::Tn10d-Cam cyxA::pPT48), FF296 (phoN::Tn10d-Cam moaA
cyxA::pPT48) and FF292 (IR715 moaA cyxA::pPT48 pduA-X::KanR), respectively.
A P22 lysate of strain FF176 was used to transduce the phoN::Tn10d-Cam mutation into
FF283 (IR715 moaA), FF489 (rhaBAD) and PT206 (fucO::pPT21) yielding strains FF294
(IR715 phoN::Tn10d-Cam moaA), FF499 (phoN::Tn10d-Cam rhaBAD) and FF509 (phoN::
Tn10d-Cam fucO::pPT21), respectively.
To restore the pduA-X::KanR mutant (FF128), an internal fragment of the pduP gene (part
of the pduA-X operon) was PCR amplified from the S. Typhimurium wild-type strain IR715
and cloned into pCR2.1 to generate pCR-pduP. The pduP fragment from pCR2.1 was cloned
into suicide plasmid pRDH10 to obtain pRDH10-pduP. Using E. coli S17-1λpir as a donor
strain, plasmid pRDH10-pduP was conjugated into S. Typhimurium wild type (IR715) yield-
ing strain FF480. A P22 lysate of strain FF480 was used to transduce pduP::pRDH10 into
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FF128. Sucrose counter-selection was performed as published previously [36]. Strains that
were sucrose resistant and CmS were verified by PCR.
In vitro growth assays
Anaerobic growth assays. Growth assays were performed in No-carbon-E (NCE) medium
[19] supplemented with trace metals (0.3 μM CaCl2, 0.1 μM ZnSO4, 0.045 μM FeSO4, 0.2 μM
Na2Se2O3, 0.2 μM Na2MoO4, 2 μM MnSO4, 0.1 μM CuSO4, 3 μM CoCl2, 0.1 μM NiSO4) and
5 mM 1,2-propanediol (Sigma-Aldrich) as the sole carbon source. For anaerobic growth, cul-
tures were incubated inside an anaerobe chamber with one of the following electron acceptors
added to the medium: 40 mM sodium tetrathionate, 40 mM sodium nitrate, 40 mM dimethyl
sulfoxide (DMSO) or 40 mM trimethylamine N-oxide (TMAO) (all purchased from Sigma-
Aldrich). For microaerobic growth cultures were incubated inside a hypoxia chamber set at
0.8% oxygen. To enhance initial growth, media were inoculated with a single strain or with an
equal mixture of indicated S. Typhimurium strains resuspended in LB and incubated at 37˚C
for 24 hours, which was based on a similar protocol [38]. Bacterial numbers were determined
by plating serial ten-fold dilutions onto LB agar containing the appropriate antibiotics. The
ratios of recovered wild-type and mutant bacteria after 24 hours were normalized to the ratio at
0 hours to calculate the competitive index.
Sugar fermentation assay. 5 ml of fermentation broth (peptone, 10 g/l; Bromothymol
blue, 0.024 g/l; final pH 7.4±0.1) supplemented with the indicated carbon source (galactarate,
glucarate, galactose, glucose, mannose or rhamnose, 10g/L each) or the control broth (no
sugar added) were inoculated with 10 μl of an over night culture of each indicated S. Typhi-
murium strain and incubated statically at 37˚C for 24 hours. Fermentation of the sugar in the
broth is indicated by a color change from blue to yellow.
Animal experiments
All animal experiments were approved by the Institutional Animal Care and Use Committees
at the University of California, Davis. Female C57BL/6J and CBA/J wild-type mice aged 8–10
weeks were obtained from The Jackson Laboratory (Bar Harbor). Germ-free Swiss-Webster
mice were bred in house.
C57BL/6 Mice were treated with an oral dose of 20 mg streptomycin 24 hours before oral
infection with 0.1 ml LB broth (mock-infected) or with 1 x 109 CFU of a 1:1 mixture of the
indicated S. Typhimurium strains. Mice were euthanized 4 days after infection, cecal and
colon contents were collected for enumeration of bacterial numbers and the cecal tip was col-
lected for histopathology scoring. Bacterial numbers were determined by plating serial ten-
fold dilutions onto LB agar containing the appropriate antibiotics.
For intraperitoneal infection, C57BL/6 mice were injected with 105 CFU of a 1:1 mixture of
the indicated S. Typhimurium strains. Mice were euthanized 2 days after infection and spleen,
liver and mesenteric lymph nodes were collected for enumeration of bacterial numbers. Tis-
sues were homogenized and bacterial numbers were determined by plating serial ten-fold dilu-
tions onto LB agar containing the appropriate antibiotics.
CBA mice were infected with either 0.1 ml of LB broth (mock-infected) or S. Typhimurium
in LB broth. For single infections, mice were inoculated with 1 x 109 CFU of the indicated S.
Typhimurium strains. For competitive infections, mice were inoculated with 1 x 109 CFU of a
1:1 mixture of the indicated strains. Fecal pellets were collected at the indicated time points to
monitor colonization over time. Mice were euthanized at 14 days after infection, cecal and
colon contents were collected for enumeration of bacterial numbers and the cecal tip was
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collected for histopathology scoring. Bacterial numbers were determined by plating serial ten-
fold dilutions onto LB agar containing the appropriate antibiotics.
Germ-free Swiss Webster mice were obtained from Taconic Farms. Mice were bred and
housed under germ-free conditions inside gnotobiotic isolators (Park Bioservices, LLC).
Weekly cultures were performed to monitor the germ-free status of the mice. For experiments,
male and female 6–8 weeks old mice were transferred to a biosafety cabinet and maintained in
sterile cages for the duration of the experiment. Each recipient germ-free mouse was orally
inoculated with TSB (mock-infected) or the indicated Bacteroides strain resuspended in TSB.
Mice were mono-colonized for 7 days with either B. thetaiotaomicron or B. fragilis before oral
challenge with an equal mixture of 109 CFU of the indicated S. Typhimurium strains. Mice
were euthanized 3 days after challenge with S. Typhimurium, cecal and colon contents were
collected for enumeration of bacterial numbers and the cecal tip was collected for histopathol-
ogy scoring. Bacterial numbers were determined by plating serial ten-fold dilutions onto LB
agar containing the appropriate antibiotics.
When mice were infected with a 1:1 mixture of bacterial strains, the ratio of recovered bacterial
strains was normalized to the ratio present in the inoculum to calculate the competitive index.
Histopathology
Cecal tissue was fixed in 10% phosphate- buffered formalin and 5 μm sections of the tissue
were stained with hematoxylin and eosin. Blinded scoring of tissue sections was performed by
a veterinary pathologist based on the criteria listed in S4 Fig. Representative images were taken
using an Olympus BX41 microscope.
1,2-propanediol measurements
Germ-free mice were orally inoculated with TSB (mock-infected) or B. thetaiotaomicron
and colonized for 7 days before oral challenge with LB (mock-infected) or 108 CFU of S.
Typhimurium wild-type or the pduA-X mutant. Mice were euthanized 3 days after challenge
with S. Typhimurium and colon contents were collected in 250 μL of sterile PBS spiked with
0.1 mM (final concentration) of deuterated 1,2-propanediol (internal standard). The sample
weights were measured for later normalizations to determine the correct concentration.
Samples were vortexed for 2 minutes at maximum speed to break up the fecal pellet and
create a homogenous solution. Samples were then centrifuged at 6,000 x g, 4˚C for 15 min-
utes, the supernatant was transferred into a new tube and stored at -80˚C for further pro-
cessing. Samples, diluted with acetonitrile at a 1:1 ratio, were incubated for 30 min at room
temperature. To remove particles, samples were centrifuged for 15 min at 20,000 g at 4˚C.
The supernatant was transferred to an autosampler vial for gas chromatography-mass spec-
trometry analysis. A Gas Chromatograph Mass Spectrometer (Shimadzu TQ-8040 GC/MS/
MS) was used with an injection temperature of 250˚C, injection split ratio of 5 and an injec-
tion volume of 1 μl. The GC oven temperature started at 100˚C for 1 min, rising to 250˚C at
10˚C/min with a final hold at this temperature for 4 min. GC flow rate with helium carrier
gas was constant at 35 cm/s. The GC column used was a 30 m × 0.25 mm × 0.25 μm Stabi-
lwax-MS (Restek). The interface temperature was 250˚C and ion source temperature was
200˚C. The mass spectrometer was set to selected-ion monitoring of the three most abun-
dant m/z, m/z 1 at 29, m/z 2 at 43, m/z 3 at 45 for 1,2-propanediol and m/z 1 at 30, m/z 2 at
33 and m/z 3 at 49 for the internal standard 1,2-propanediol-d6. m/z at 45 and m/z at 49
were used to quantify 1-2-propanediol and 1,2-propanediol-d6 respectively, while the other
m/z were used as qualifying ions [39]. Recovery was calculated based on the internal stan-
dard. An external standard curve was run in triplicate for quantification.
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Statistical analysis
Student’s t-test was performed on logarithmically transformed values for bacterial numbers
and competitive indices. A non-parametric test (Man Whitney) was used for comparing histo-
pathology scores.
Supporting Information
S1 Fig. Growth of S. Typhimurium strains in rich medium. (A-C) Rich medium (LB broth)
was inoculated with one of the indicated S. Typhimurium strains and bacterial growth moni-
tored by measuring the optical density at 600 nm (OD600). Each experiment was repeated
three times independently.
(PDF)
S2 Fig. The S. Typhimurium pduC mutant is attenuated during growth in the inflamed
murine intestine, but not for growth in organs. (A) CBA mice were infected intragastrically
with a 1:1 mixture of the indicated S. Typhimurium strains. Bars represent geometric means ±
s.e.m. of the CFU recovered for each strain at 14 days after infection. (B) CBA mice (N = 6)
were infected intragastrically with a 1:1 mixture of S. Typhimurium wild type and a pduC
mutant. (C) C57BL/6 mice (N = 4) were infected intraperitoneally with a 1:1 mixture of S.
Typhimurium wild type and a pduA-X mutant. (D) CBA mice (N = 6) were infected intragas-
trically with a 1:1 mixture of a pduA-X mutant and a strain in which the pduA-X mutation had
been restored by introducing the intact pdu operon through transduction. (A-C) Bars repre-
sent geometric means ± s.e.m. of the competitive indices. (E) Histopathological changes were
scored in sections of the cecum for the experiment shown in Fig 1D. Each bar represents the
combined scoring results for one individual animal. , P< 0.05; , P< 0.01; MLN, mesenteric
lymph node.
(PDF)
S3 Fig. 1,2-propanediol utilization confers a fitness advantage in C57BL/6 mice. Strepto-
mycin-treated C57BL/6 mice were infected intragastrically with a 1:1 mixture of the indicated
S. Typhimurium strains. Bars represent geometric means ± s.e.m. of the CFU recovered for
each strain at 4 days after infection.
(PDF)
S4 Fig. Scoring criteria for the blinded examination of H&E stained cecal tissue sections.
Criteria for blinded scoring performed by a veterinary pathologist.
(PDF)
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